Hopefully the dramatic "results" really are the leronlimab group separating from the control group rather than a hopeful eye categorizing the good labs as "leronlimab" and the not-so-good labs as "control". No one knows at this point because no single person knows both the lab (or clinical) results and the treatment group. Really, no one.